PAPER Beste C, Güntürkün O, Baune BT, Domschke K, Falkenstein M, Konrad C

Double dissociated effects of the functional TNF-α-308G/A polymorphism on processes of cognitive control.

Neuropsychologia. 2011 Jan;49(2):196-202. PubMed: 21130787

PAPER Villalonga-Barber C, Meligova AK, Alexi X, Steele BR, Kouzinos CE, Screttas CG, Katsanou ES, Micha-Screttas M, Alexis MN

New hydroxystilbenoid derivatives endowed with neuroprotective activity and devoid of interference with estrogen and aryl hydrocarbon receptor-mediated transcription.

Bioorg Med Chem. 2011 Jan 1;19(1):339-51. PubMed: 21129978

PAPER Schieb H, Weidlich S, Schlechtingen G, Linning P, Jennings G, Gruner M, Wiltfang J, Klafki HW, Knölker HJ

Structural design, solid-phase synthesis and activity of membrane-anchored β-secretase inhibitors on Aβ generation from wild-type and Swedish-mutant APP.

Chemistry. 2010 Dec 27;16(48):14412-23. PubMed: 21132705

PAPER Dai H, Navath RS, Balakrishnan B, Guru BR, Mishra MK, Romero R, Kannan RM, Kannan S

Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration.

Nanomedicine (Lond). 2010 Nov;5(9):1317-29. PubMed: 21128716

PAPER Yoon MY, Hwang JH, Park JH, Lee MR, Kim HJ, Park E, Park HR

Neuroprotective effects of SG-168 against oxidative stress-induced apoptosis in PC12 cells.

J Med Food. 2011 Jan-Feb;14(1-2):120-7. PubMed: 21128832

PAPER Pedersen JS

The nature of amyloid-like glucagon fibrils.

J Diabetes Sci Technol. 2010 Nov;4(6):1357-67. PubMed: 21129330

PAPER Jardanhazi-Kurutz D, Kummer MP, Terwel D, Vogel K, Thiele A, Heneka MT

Distinct adrenergic system changes and neuroinflammation in response to induced locus ceruleus degeneration in APP/PS1 transgenic mice.

Neuroscience. 2011 Mar 10;176:396-407. PubMed: 21129451

PAPER Zhao R, Zhang Z, Song Y, Wang D, Qi J, Wen S

Implication of phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3β pathway in ginsenoside Rb1's attenuation of beta-amyloid-induced neurotoxicity and tau phosphorylation.

J Ethnopharmacol. 2011 Feb 16;133(3):1109-16. PubMed: 21129477

PAPER Yu JT, Wang ND, Ma T, Jiang H, Guan J, Tan L

Roles of β-adrenergic receptors in Alzheimer's disease: implications for novel therapeutics.

Brain Res Bull. 2011 Feb 1;84(2):111-7. PubMed: 21129453

PAPER Braskie MN, Medina LD, Rodriguez-Agudelo Y, Geschwind DH, Macias-Islas MA, Cummings JL, Bookheimer SY, Ringman JM

Increased fMRI signal with age in familial Alzheimer's disease mutation carriers.

Neurobiol Aging. 2012 Feb;33(2):424.e11-21. PubMed: 21129823

PAPER Kaźmierczak A, Czapski GA, Adamczyk A, Gajkowska B, Strosznajder JB

A novel mechanism of non-Aβ component of Alzheimer's disease amyloid (NAC) neurotoxicity. Interplay between p53 protein and cyclin-dependent kinase 5 (Cdk5).

Neurochem Int. 2011 Feb;58(2):206-14. PubMed: 21130128

PAPER Kular L, Pakradouni J, Kitabgi P, Laurent M, Martinerie C

The CCN family: a new class of inflammation modulators?

Biochimie. 2011 Mar;93(3):377-88. PubMed: 21130134

PAPER Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, Weiner M, Winblad B, Coley N, Vellas B,

Biomarkers for Alzheimer's disease therapeutic trials.

Prog Neurobiol. 2011 Dec;95(4):579-93. PubMed: 21130138

PAPER Glorioso C, Sibille E

Between destiny and disease: genetics and molecular pathways of human central nervous system aging.

Prog Neurobiol. 2011 Feb;93(2):165-81. PubMed: 21130140

PAPER Dumont M, Beal MF

Neuroprotective strategies involving ROS in Alzheimer disease.

Free Radic Biol Med. 2011 Sep 1;51(5):1014-26. PubMed: 21130159